Oramed Pharmaceuticals Congress Trades
NASDAQ: ORMPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0
- Sales
- 0
- Politicians trading
- 0
- Latest trade
- Jan 10, 2025
Oramed Pharmaceuticals Congress trading summary
Members of Congress have disclosed 4 transactions in Oramed Pharmaceuticals (ORMP) stock, reported by 2 politicians. No ORMP trades were reported with a transaction date in the past 12 months. The most active traders are Rep. Andrew R. Garbarino (3), Rep. Brad Knott (1).
The latest reported trade is a sale by Brad Knott dated Jan 10, 2025 and disclosed on Feb 25, 2025. The most common reported amount is $1,001 – $15,000; disclosures list value ranges, not exact amounts.
Summary generated from market data by MetaCap's automated system. Methodology
Politicians trading ORMP
ORMP trades by members of Congress
| Politician | Type | Amount | Traded | Filing |
|---|---|---|---|---|
 Brad KnottR-NCHouse | Sell | $15,001 – $50,000 | Jan 10, 2025 | Filing for Brad Knott ORMP trade |
 Andrew R. GarbarinoR-NYHouse | Sell | $1,001 – $15,000 | Jan 14, 2022 | Filing for Andrew R. Garbarino ORMP trade |
| Andrew R. GarbarinoR-NYHouse | Partial sell | $1,001 – $15,000 | Oct 1, 2021 | Filing for Andrew R. Garbarino ORMP trade |
| Andrew R. GarbarinoR-NYHouse | Buy | $1,001 – $15,000 | Apr 23, 2021 | Filing for Andrew R. Garbarino ORMP trade |
Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction.
Related
Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction. Disclosures are shown as filed and are not a recommendation to buy or sell ORMP. How Congress trading data works